seed
Stage
1
Investors
About
Perpetual Medicines develops computational peptide therapeutics using AI and advanced synthetic chemistry to target previously undruggable targets, focusing on accelerating peptide drug discovery for diseases such as cancer.
Explore Perpetual Medicines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.